NCT03691883 Design of an Integrative Algorithm for Staging Tuberculosis
| NCT ID | NCT03691883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundació Institut Germans Trias i Pujol |
| Condition | Tuberculosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2018-04-19 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2018-04-19 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Tuberculosis is a chronic infectious disease that affects 10 million people, 300 in the city of Barcelona, every year. With serious consequences at public health level, it is associated with other diseases, and generated and influenced by many social and psychological factors. This study aims to stage tuberculosis disease by an integrative approach.
Eligibility Criteria
Inclusion Criteria: * TB diagnosis (all forms), microbiologically confirmed (by AFB+, GenXpert+ or Culture+) * Clinical management of the patients being done at Servicios Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol. Exclusion Criteria: * Not consenting to data/samples donation
Contact & Investigator
Cris Vilaplana, MD, PhD
PRINCIPAL INVESTIGATOR
Fundació Institut Germans Trias i Pujol
Frequently Asked Questions
Who can join the NCT03691883 clinical trial?
This trial is open to participants of all sexes, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03691883 currently recruiting?
Yes, NCT03691883 is actively recruiting participants. Contact the research team at cvilaplana@gmail.com for enrollment information.
Where is the NCT03691883 trial being conducted?
This trial is being conducted at Badalona, Spain, Esplugues de Llobregat, Spain, Barcelona, Spain, Barcelona, Spain and 1 additional location.
Who is sponsoring the NCT03691883 clinical trial?
NCT03691883 is sponsored by Fundació Institut Germans Trias i Pujol. The principal investigator is Cris Vilaplana, MD, PhD at Fundació Institut Germans Trias i Pujol. The trial plans to enroll 200 participants.